(Q83519037)
Statements
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab (English)
A Ruyssen-Witrand
S Rouanet
B Combe
M Dougados
X Le Loët
J Sibilia
J Tebib
X Mariette
25 February 2012